N: normal
(*): mmol/l
(**): Ultrasonido abdominal renal y prostático

Comportamiento glicemia (expresada en mh/dl) 

Comportamiento leucocitos 

Referencias Bibliográficas.

Bibliografía

1. Acosta JB, del Barco DG, Vera DC, Savigne W, López-Saura P, Nieto GG, et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J. 2008;5:530-39
2. Torres HO. Diabetes mellitus. Tipos y etapas de esta enfermedad. En: Torres HO. Controlar su diabetes. La Habana: Editorial Científico-Técnica; 2007. p. 2-16.
3. García HAL, Fernández MJ. Generalidades del pie diabético. En: García HAL, Fernández MJI, Rodríguez FR. El pie diabético. Madrid: Elsevier; 2004. p. 1-27
4. Frykberg GR, Armstrong GD, Giurini J, Edward A, Kravettle M, Kravitz S, et al. Diabetic foot disorders. A clinical practice guideline: for the American collage of foot and ankle surgeons and the American collage of foot and ankle orthopedic and medicine. The Journal of Foot & Ankle Surgery. 2000;39(5):1-60.
5. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555-62.
6. Berlanga,J; Moreira,E. Wound healing promotion in rats treated with EGF is dose dependent. Biotecnologia Aplicada, 1996, Vol. 13, No. 3;pp 181-185
7. Montequín FJI, Infante CE, Valenzuela SC, Franco PN, Savigne GW, Artaza SH, et al. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. International Wound Journal. 2007;4(4):333-43.
8. Fernandez Montequin,J; Berlanga, J, Valdes, C; Franco,N;Savigne, W : Epidermal Growth Factors intralesional infiltrations can prevent amputation in patients with advanced diabetic wounds.Int. Wound J. 2006(1-8)
9. Acosta JB, Savigne W, Valdez C, Franco N, Alba JS, del Río A, et al. Epidermal growth factor intralesional infiltrations can prevent amputation in patient with advanced diabetic foot wounds. Int
10. Wound J. 2006;3:231-9.